Highlights
• Engineered probiotics are emerging as active agents in wound healing, capable of modulating immuneresponses, enhancing epithelialization, and combating infections.
• This review comprehensively integrates key advances in probiotic-mediated immunomodulatory mechanisms and engineering strategies designed to enhance probiotic delivery and function in skin wound healing.
• A CXCL12-producing engineered Lactobacillus reuteri strain demonstrated accelerated wound repair in murine, minipig, and human clinical studies, and is now progressing through Phase II trials.
• A multi-cytokine-engineered Leuconostoc cremoris secreting FGF-2, IL-4, and CSF-1 accelerated wound healing in diabetic mice and achieved 83% complete closure in a Phase I DFU trial, confirming its regenerative and immunomodulatory potential.
• Smart wound healing platforms integrating engineered probiotics, responsive biomaterials, and real-time sensing technologies represent a transformative frontier in trauma care.

京公网安备11010802044758号
Comments on this article